| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neuroradiology (Drs. Bühring and Küker) and Neurology (Drs. Herrlinger and Weller), Medical School, University of Tübingen; and Departments of Neuroradiology (Dr. Krings) and Neurosurgery (Dr. Thiex), Medical School, Technical University Aachen, Germany.
Address correspondence and reprint requests to Dr. Wilhelm Küker, Department of Neuroradiology, University of Tübingen, Hoppe-Seyler-Str. 3, D-72076 Tübingen, Germany; e-mail: wmkueker{at}med.uni-tuebingen.de
Pretreatment MRI examinations of 40 immunologically competent patients with primary CNS lymphoma (PCNSL) were evaluated (24 men, 16 women, median age 63 years). Seventy lesions were found (mean size: 19.9 mm). The number of lesions ranged from one (n = 25) to six (n = 1). The most frequent locations were the cerebral hemispheres (n = 22), the corpus callosum (n = 11), and the basal ganglia (n = 11). Cerebellar manifestations were found in 10 patients. Ocular (n = 2) and medullary cord (n = 1) manifestations were rare. Contrast enhancement was encountered in all lesions. Although 39 patients had lesions adjacent to the CSF space, leptomeningeal spread was only present in five patients. Necrosis was seen in two lesions only. Edema was extensive in 24 patients, moderate in 11 patients, and absent in five patients. Contrast-enhancing lesions in contact with the subarachnoid space and without necrosis are characteristic of PCNSL.
This article has been cited by other articles:
|
|
 |
|
  R. N. Al-Okaili, J. Krejza, J. H. Woo, R. L. Wolf, D. M. O'Rourke, K. D. Judy, H. Poptani, and E. R. Melhem Intraaxial Brain Masses: MR Imaging-based Diagnostic Strategy--Initial Experience Radiology, May 1, 2007; 243(2): 539 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kiewe, C. Loddenkemper, I. Anagnostopoulos, M. Reinwald, E. Thiel, and A. Korfel High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma Neuro-oncol, April 1, 2007; 9(2): 96 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Weber, S. Zoubaa, M. Schlieter, E. Juttler, H. B. Huttner, K. Geletneky, C. Ittrich, M. P. Lichy, A. Kroll, J. Debus, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors Neurology, June 27, 2006; 66(12): 1899 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Trendelenburg, C. Zimmer, A. Forschler, C. Stadelmann, and R. Zschenderlein Atypical appearance of a primary central nervous system lymphoma. Arch Neurol, June 1, 2006; 63(6): 908 - 909. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jahnke, A. Schilling, J. Heidenreich, H. Stein, M. Brock, E. Thiel, and A. Korfel Radiologic Morphology of Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2446 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Kuker, T. Nagele, E. Thiel, M. Weller, and U. Herrlinger Primary central nervous system lymphomas (PCNSL): MRI response criteria revised Neurology, October 11, 2005; 65(7): 1129 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Batchelor, B. R. Buchbinder, and N. L. Harris Case 1-2005 - A 35-Year-Old Woman with Difficulty Walking, Headache, and Nausea N. Engl. J. Med., January 13, 2005; 352(2): 185 - 194. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pittock, B. G. Weinshenker, and C. F. Lucchinetti Bright red nuclei Neurology, February 24, 2004; 62(4): 619 - 619. [Full Text] [PDF]
|
|
|
|
|
|
R. Lai, M. K. Rosenblum, and L. M. DeAngelis Primary CNS lymphoma: A whole-brain disease? Neurology, November 26, 2002; 59(10): 1557 - 1562. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
